HOXD3 and hepatocellular carcinoma: In vivo metastasis assay further confirmed that HCC-HOXD3-exosomes enhanced bioluminescent imaging (BLI) signals (Fig. 2C), increased liver metastasis incidence (Fig. 2D), and reduced overall survival in the HCC-HOXD3-exosome group (Fig. 2E).